IMD-1041 Chronic Obstructive Pulmonary Disease: Proof of Concept (POC) Study

NCT00883584 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: IMD-1041
DRUG: Placebo

Sponsor

Institute of Medicinal Molecular Design, Inc.